Advanced search
Publication Cover
Expert Review of Vaccines Volume 15, 2016 - Issue 9: Vaccines for Biodefense
Submit an article Journal homepage
1,311
Views
28
CrossRef citations to date
0
Altmetric
Review

Vaccine platforms to control Lassa fever

Igor S. LukashevichDepartment of Pharmacology and Toxicology, School of Medicine, and the Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY, USACorrespondence[email protected]
&
Peter PushkoMedigen, Inc., Frederick, MD, USA
Pages 1135-1150 | Received 04 Mar 2016, Accepted 27 Apr 2016, Published online: 24 May 2016

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bryce M Warner, David Safronetz & Derek R Stein. (2018) Current research for a vaccine against Lassa hemorrhagic fever virus. Drug Design, Development and Therapy 12, pages 2519-2527.
Read now

Articles from other publishers (27)

Takeshi Saito, Rachel A. Reyna, Satoshi Taniguchi, Kirsten Littlefield, Slobodan Paessler & Junki Maruyama. (2023) Vaccine Candidates against Arenavirus Infections. Vaccines 11:3, pages 635.
Crossref
Sumit Kumar, Dharna Yadav, Divya Singh, Kriti Shakya, Brijesh Rathi & Poonam. (2023) Recent developments on Junin virus, a causative agent for Argentine haemorrhagic fever. Reviews in Medical Virology 33:2.
Crossref
Phillip R. Pittman, Gunnstein Norheim, Benjamin Pierson & Fernando B. Guerena. 2023. Plotkin's Vaccines. Plotkin's Vaccines 172 190.e9 .
Qianqian Li, Weijing Huang & Youchun Wang. 2023. Pseudotyped Viruses. Pseudotyped Viruses 279 297 .
Rachel A. Reyna, Junki Maruyama, Emily K. Mantlo, John T. Manning, Satoshi Taniguchi, Tomoko Makishima, Igor S. Lukashevich & Slobodan Paessler. (2022) Depletion of CD4 and CD8 T Cells Reduces Acute Disease and Is Not Associated with Hearing Loss in ML29-Infected STAT1-/- Mice. Biomedicines 10:10, pages 2433.
Crossref
Kenneth Lundstrom. (2022) Therapeutic and prophylactic applications of self-replicating RNA viruses. Exploration of Immunology, pages 264-292.
Crossref
Kenneth Lundstrom. 2022. mRNA-Based Therapeutics. mRNA-Based Therapeutics 97 157 .
Kenneth Lundstrom. (2021) Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer. Vaccines 9:10, pages 1187.
Crossref
O C Collins & J E Okeke. (2021) Analysis and control measures for Lassa fever model under socio-economic conditions. Journal of Physics: Conference Series 1734:1, pages 012049.
Crossref
Akinyemi Ademola Omoniyi, Samuel Sunday Adebisi, Sunday Abraham Musa, James Oliver Nzalak, Barnabas Danborno, Zainab Mahmood Bauchi, Iswat Taiwo Badmus, Oluwasegun Davis Olatomide, Olalekan Jerry Oladimeji & Jens Randel Nyengaard. (2021) Designing a multi-epitope vaccine against the Lassa virus through reverse vaccinology, subtractive proteomics, and immunoinformatics approaches. Informatics in Medicine Unlocked 25, pages 100683.
Crossref
Ifeanyi Sunday Onah & Obiora Cornelius Collins. (2020) Dynamical System Analysis of a Lassa Fever Model with Varying Socioeconomic Classes. Journal of Applied Mathematics 2020, pages 1-12.
Crossref
Peter D. Kwong, Brandon J. DeKosky & Jeffrey B. Ulmer. (2020) Antibody-guided structure-based vaccines. Seminars in Immunology 50, pages 101428.
Crossref
Ifeanyi Sunday Onah, Obiora Cornelius Collins, Praise-God Uchechukwu Madueme & Godwin Christopher Ezike Mbah. (2020) Dynamical System Analysis and Optimal Control Measures of Lassa Fever Disease Model. International Journal of Mathematics and Mathematical Sciences 2020, pages 1-18.
Crossref
Timothy P. Endy. 2020. Hunter's Tropical Medicine and Emerging Infectious Diseases. Hunter's Tropical Medicine and Emerging Infectious Diseases 351 381 .
Raphaëlle Klitting, Samar B. Mehta, Judith U. Oguzie, Paul E. Oluniyi, Matthias G. Pauthner, Katherine J. Siddle, Kristian G. Andersen, Christian T. Happi & Pardis C. Sabeti. 2023. Lassa Fever: Epidemiology, Immunology, Diagnostics, and Therapeutics. Lassa Fever: Epidemiology, Immunology, Diagnostics, and Therapeutics 23 65 .
Jyothi Purushotham, Teresa Lambe & Sarah C. Gilbert. (2019) Vaccine platforms for the prevention of Lassa fever. Immunology Letters 215, pages 1-11.
Crossref
Mathieu Mateo, Stéphanie Reynard, Xavier CarnecAlexandra JourneauxNicolas BailletJustine SchaefferCaroline PicardCatherine Legras-Lachuer, Richard AllanEmeline Perthame, Kenzo-Hugo Hillion, Natalia PietrosemoliMarie-Agnès DilliesLaura BarrotAudrey VallveStéphane BarronLyne FellmannJean-Charles GaillardJean Armengaud, Caroline Carbonnelle, Hervé RaoulFrédéric Tangy & Sylvain Baize. (2019) Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot. Science Translational Medicine 11:512.
Crossref
Kolawole Salami, Dimitrios Gouglas, Connie Schmaljohn, Melanie Saville & Nadia Tornieporth. (2019) A review of Lassa fever vaccine candidates. Current Opinion in Virology 37, pages 105-111.
Crossref
Morgan E. Brisse & Hinh Ly. (2019) Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors. Frontiers in Immunology 10.
Crossref
Devy M Emperador, Solomon A Yimer, Laura T Mazzola, Gunnstein Norheim & Cassandra Kelly-Cirino. (2019) Diagnostic applications for Lassa fever in limited-resource settings. BMJ Global Health 4:Suppl 2, pages e001119.
Crossref
Laura T Mazzola & Cassandra Kelly-Cirino. (2019) Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings. BMJ Global Health 4:Suppl 2, pages e001116.
Crossref
Dylan Johnson, Jenny Jokinen & Igor Lukashevich. (2019) Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1-/- Mice. Pathogens 8:1, pages 9.
Crossref
Igor S. Lukashevich, Slobodan Paessler & Juan Carlos de la Torre. (2019) Lassa virus diversity and feasibility for universal prophylactic vaccine. F1000Research 8, pages 134.
Crossref
Mutsuyo Takayama-Ito, Chang-Kweng Lim, Yukie Yamaguchi, Guillermo Posadas-Herrera, Hirofumi Kato, Itoe Iizuka, Md. Taimur Islam, Kinjiro Morimoto & Masayuki Saijo. (2018) Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge. PLOS Neglected Tropical Diseases 12:4, pages e0006398.
Crossref
Hoai J. Hallam, Steven Hallam, Sergio E. Rodriguez, Alan D. T. Barrett, David W. C. Beasley, Arlene Chua, Thomas G. Ksiazek, Gregg N. Milligan, Vaseeharan Sathiyamoorthy & Lisa M. Reece. (2018) Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development. npj Vaccines 3:1.
Crossref
Phillip R. Pittman & Stanley A. Plotkin. 2018. Plotkin's Vaccines. Plotkin's Vaccines 149 160.e7 .
Qianqian Li, Qiang Liu, Weijin Huang, Jiajing Wu, Jianhui Nie, Meng Wang, Chenyan Zhao, Li Zhang & Youchun Wang. (2017) An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine 35:38, pages 5172-5178.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.